ArticleJournal of neuroendovascular therapy2026
Intra-Distal Access Catheter Deployment of the Surpass Evolve Device: A Novel Technique to Prevent Advancement of the Delivery Wire: A Case Report and Literature Review.
Article in Journal of neuroendovascular therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Flow diverter stent (FDS) deployment in neuroendovascular therapy carries a risk of vessel injury related to unintended distal advancement of the delivery wire, particularly in cases with distal aneurysms. Safe control of wire behavior during deployment remains challenging. We describe a deployment strategy using a distal access catheter (DAC) to mitigate this risk. Case Presentation: We report a case of a 79-year-old man with multiple intracranial aneurysms, including a symptomatic large aneurysm of the right internal carotid artery and an additional distal aneurysm at the middle cerebral artery bifurcation. A Surpass Evolve Flow Diverter (Stryker, Kalamazoo, MI, USA) was deployed in the right internal carotid artery. The device was initially deployed using the standard technique; however, the deployment strategy was subsequently changed to release the device within the DAC, followed by gradual unsheathing of the catheter, to mitigate the risk of distal advancement of the delivery wire. The FDS was successfully deployed without distal wire migration or vessel injury. The postoperative course was uneventful, with no procedure-related complications. Conclusion: This case highlights a practical rescue strategy for situations in which distal wire control during FDS deployment is particularly important. Deploying an FDS within a DAC and releasing it by unsheathing may help mitigate the risk of uncontrolled distal wire advancement and enhance procedural safety in carefully selected complex cases with distal aneurysms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.